Acumen Pharmaceuticals Files 424B3 Prospectus
Ticker: ABOS · Form: 424B3 · Filed: 2026-04-01T17:15:48-04:00
Sentiment: neutral
Topics: prospectus, offering, filing
TL;DR
Acumen Pharma dropped a 424B3 filing on 4/1/26 - check it for offering details.
AI Summary
Acumen Pharmaceuticals, Inc. filed a 424B3 prospectus on April 1, 2026, detailing its offerings. The company, located at 1210-1220 Washington Street, Suite 210, Newton, MA 02465, is involved in the Biological Products industry.
Why It Matters
This filing provides crucial details for investors regarding Acumen Pharmaceuticals' securities offerings, impacting potential investment decisions.
Risk Assessment
Risk Level: low — A 424B3 filing is a standard prospectus supplement and does not inherently indicate increased risk.
Key Players & Entities
- Acumen Pharmaceuticals, Inc. (company) — Filer
- 0001576885 (company) — CIK
- 364108129 (company) — EIN
- DE (company) — State of Incorp.
- 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 (company) — Mailing and Business Address
- 617-344-4190 (company) — Business Phone Number
- 2836 (company) — SIC Code
- 03 (company) — CF Office
- 333-294649 (company) — File Number
- 26829434 (company) — Film Number
FAQ
What type of filing is this for Acumen Pharmaceuticals, Inc.?
This is a 424B3 filing, which is a prospectus supplement.
When was this filing submitted to the SEC?
The filing date was April 1, 2026.
What is the business address of Acumen Pharmaceuticals, Inc.?
The business address is 1210-1220 Washington Street, Suite 210, Newton, MA 02465.
What is the CIK number for Acumen Pharmaceuticals, Inc.?
The CIK number is 0001576885.
What industry does Acumen Pharmaceuticals, Inc. operate in?
Acumen Pharmaceuticals, Inc. operates in the Biological Products industry, specifically SIC code 2836.
From the Filing
EDGAR Filing Documents for 0001628280-26-022853 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 424B3 - Prospectus [Rule 424(b)(3)]: SEC Accession No. 0001628280-26-022853 Filing Date 2026-04-01 Accepted 2026-04-01 17:15:48 Documents 1 Document Format Files Seq Description Document Type Size 1 424B3 acumenpharmaceuticalsfinal.htm 424B3 132498 Complete submission text file 0001628280-26-022853.txt 133560 Mailing Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 Business Address 1210-1220 WASHINGTON STREET SUITE 210 NEWTON MA 02465 617-344-4190 Acumen Pharmaceuticals, Inc. (Filer) CIK : 0001576885 (see all company filings) EIN. : 364108129 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B3 | Act: 33 | File No.: 333-294649 | Film No.: 26829434 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)